As more details of RNR structure, function, and clinical importance have come to light, novel RNR inhibitors in different categories will further contribute to cancer chemotherapy, by affecting tumor initiation, progression, and therapeutic sensitivity. This evidence concerns the gene NR2E3 and neoplasm.